Which has the lower trailing P/E, CHE or UHS?

UHS has the lower trailing P/E: CHE trades at 26.26 and UHS at 7.08. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, CHE or UHS?

Over the past five years, UHS grew revenue faster — CHE at a 4.12% CAGR versus UHS at 8.21%.

Does CHE or UHS pay a bigger dividend?

CHE yields 0.48% and UHS yields 0.46% based on trailing dividends and the latest price.

Is CHE or UHS more profitable?

CHE runs the higher net margin — CHE at 10.60% versus UHS at 8.42%.

How have CHE and UHS total returns compared?

Over the past 10 years, CHE delivered 15.21% and UHS delivered 4.20% annualized total return. Past performance doesn't predict future results.

Chemed Corporation (CHE) vs Universal Health Services, Inc. (UHS)

A side-by-side comparison of Chemed Corporation and Universal Health Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 28, 2026. Differences are shown without an overall score or investment verdict.

CHE

Chemed Corporation

$6.84B

$523.38HealthcareDelayed quote: Aug 28, 2026, 4:00 PM EDT

UHS

Universal Health Services, Inc.

$10.39B

$171.66HealthcareDelayed quote: Aug 28, 2026, 4:00 PM EDT

Total return — CHE vs UHS

growth of $100 · dividends reinvested · last 10y

CHE +329.4% (+15.7%/yr)UHS +50.5% (+4.2%/yr)CHE compounded faster over this window

CHE UHS

CHE vs UHS: by the numbers

•UHS is the larger company ($10.39B vs $6.84B market cap).
•UHS trades at the lower trailing earnings multiple (7.08 vs 26.26 P/E), one valuation lens rather than an overall verdict.
•CHE converts more revenue to profit (10.60% vs 8.42% net margin).
•UHS grew revenue faster over the past five years (8.21% vs 4.12% CAGR).
•CHE pays the higher dividend yield (0.48% vs 0.46%).

Metrics side by side

Valuation

Metric	CHE	UHS
P/E ratio	26.26	7.08
Forward P/E	20.49	7.65
P/S ratio	2.71	0.57
P/B ratio	8.45	1.38
EV / EBITDA	17.59	5.73
FCF yield	4.61%	7.99%

Profitability

Metric	CHE	UHS
Gross margin	30.44%	90.69%
Operating margin	13.46%	11.36%
Net margin	10.60%	8.42%
ROE	33.11%	20.31%
ROIC	19.48%	11.74%

Dividends

Metric	CHE	UHS
Dividend yield	0.48%	0.46%
Payout ratio	13.57%	3.42%

Growth (annualized)

Metric	CHE	UHS
Revenue CAGR (5Y)	4.12%	8.21%
EPS CAGR (5Y)	-1.65%	16.19%
FCF CAGR (5Y)	-5.44%	-12.18%
Total return CAGR (5Y)	2.38%	2.47%

Frequently asked

Which has the lower trailing P/E, CHE or UHS?: UHS has the lower trailing P/E: CHE trades at 26.26 and UHS at 7.08. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, CHE or UHS?: Over the past five years, UHS grew revenue faster — CHE at a 4.12% CAGR versus UHS at 8.21%.
Does CHE or UHS pay a bigger dividend?: CHE yields 0.48% and UHS yields 0.46% based on trailing dividends and the latest price.
Is CHE or UHS more profitable?: CHE runs the higher net margin — CHE at 10.60% versus UHS at 8.42%.
How have CHE and UHS total returns compared?: Over the past 10 years, CHE delivered 15.21% and UHS delivered 4.20% annualized total return. Past performance doesn't predict future results.

Go deeper

Full CHE analysis Full UHS analysis Interactive comparison tool

Dig into the metrics

Chemed P/E ratio Universal Health Services P/E ratio Chemed dividend yield Universal Health Services dividend yield Chemed ROE Universal Health Services ROE Chemed operating margin Universal Health Services operating margin Chemed revenue growth Universal Health Services revenue growth Chemed free cash flow Universal Health Services free cash flow

Chemed & Universal Health Services appear in these rankings

Highest ROE Stocks Highest ROIC Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 28, 2026.